Law360, New York (October 21, 2009) -- Guidant Corp. has prevailed in a challenge by investors to the dismissal of a putative securities class action that alleged the medical device maker glossed over problems with its defibrillators and their impact on its aborted merger with Johnson & Johnson, leading to billions of dollars in shareholder losses.
On Wednesday the U.S. Court of Appeals for the Seventh Circuit affirmed a district court's February 2008 decision to grant Guidant's motion to toss the consolidated case with prejudice, saying...
